Position in RLAY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$10,384
New position
Shares Held
555
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#234
of 256 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026J.Safra Asset Management Corp holds $2,957,680 across 41 Biotechnology names. RLAY ranks #22 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,122 | $939,815 | |
| 2 | INSM |
INSMED Inc
|
7,650 | $815,643 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
12,564 | $730,345 | |
| 4 | ASND |
Ascendis Pharma A/S
|
121 | $32,273 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
695 | $26,896 | |
| 6 | ARGX |
Argenx SE
|
26 | $24,122 | |
| 7 | TECH |
BIO-TECHNE Corp
|
338 | $23,879 | |
| 8 | MRNA |
Moderna, Inc.
|
328 | $22,969 |
All Filings in RLAY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,384 | 555 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||